MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

March 2004


Health Care and Law

Stem Cell Researchers Face an Unsettled Legal Environment

The author reviews the recent progress in the area of stem cell technology and discusses the obstacles to further development in the U.S..
Robert I. Field, JD, MPH, PhD

Pharmaceutical-Approval Update: Oncology

Three antineoplastic agents are described: intravenous cetuximab for metastatic colorectal cancer, injected pemetrexed for malignant pleural mesothelioma, and injected oxaliplatin for recurrent or metastatic colorectal cancer.
Marvin M. Goldenberg, PhD, RPh, MS

Safety and Tolerability of Tegaserod for Irritable Bowel Syndrome

Dr. Howden reviews tegaserod maleate (Zelnorm™) and its role in patients with multiple gastrointestinal problems.
Colin W. Howden, MD

Pharmacists’ Job Satisfaction: Variation by Practice Setting

Pharmacists respond to a nationwide survey about their likes and dislikes on the job.
Vittorio Maio, PharmD, MS, Neil I. Goldfarb, and Christine W. Hartmann, MSS

Meeting Highlights

Highlights of the American Stroke Association’s 29th International Stroke Conference

Dr. Prescott reports on a combined thrombolytic/glycoprotein receptor blocker therapy for middle cerebral artery occlusion, a thrombin inhibitor, a low-dose thrombolytic agent, an astrocyte activation modulator, a new investigational agent, amphetamine therapy plus physiotherapy, statins for brain infarction, and recombinant factor VIIa for correcting warfarin anticoagulation.
Lawrence M. Prescott, PhD




David Nash, MD, MBA, discusses articles that followed up on themes in earlier P&T editorials on ALLHAT and counterfeit drugs.
David Nash, MD, MBA

Letters to the Editor

Editorial Board Spotlight

Meet Matt, Mister Medication Safety

Matthew Grissinger discusses his background in pharmacy and his role at the Institute for Safe Medication Practices.
Sonja Sherritze

Prescription Washington

Getting Drug Ads to Add Up: The FDA Thinks Less Is More

Stephen Barlas comments on the FDA’s draft guidance calling for clearer language in the “brief” summaries in drug package inserts.
Stephen Barlas

Medication Errors

Shedding “Lyte” on the Multifaceted Nature of Errors

Matthew Grissinger, RPh, FASCP, describes a mix-up that occurred when sodium acetate was confused with potassium acetate.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

Drug Forecast

Memantine: A New Treatment Option for Patients with Moderate-to-Severe Alzheimer’s Disease

Yvonne Ho and Larisa Chagan review memantine (Namenda™) for moderate-to-severe Alzheimer’s disease.
Yvonne Ho, PharmD Candidate, and Larisa Chagan, BS, PharmD, BCPS

P&T Snapshot

Hospitalization Patterns for Stroke